Transactions & Cases Detail



Transaction/Case Details

Schlegel Health Care completes C$136 million acquisition of Homewood Corporation

DATE CLOSED

December 2, 2010

BUSINESS SECTOR

Healthcare

LEAD OFFICE

Toronto

VALUE

136 Million CAD


OVERVIEW

On December 2, 2010, Schlegel Health Care Inc., a wholly owned indirect subsidiary of RBJ Schlegel Holdings Inc., announced the final results of its offer to purchase all of the outstanding common shares of The Homewood Corporation, other than shares beneficially owned or over which control or direction is exercised by Schlegel Health Care or its affiliates, for C$68 in cash per common share. The shares acquired pursuant to the offer represented 94.9% of the outstanding shares of Homewood not already owned by Schlegel Health Care or its affiliates.

The total purchase price for the shares of Homewood was C$136 million.

Financing for the acquisition was provided by The Toronto-Dominion Bank and by Canadian Imperial Bank of Commerce.

The Homewood Corporation, headquartered in Guelph, Ontario, is active in mental, behavioural and addiction health care, employee assistance programs and continuum of care retirement living alternatives.

McCarthy Tétrault LLP represented Schlegel Health Care, the acquiror, with a team led by Graham Gow.

Contact


 
For general information on McCarthy Tétrault Transactions & Cases, please contact [email protected].

Related Area of Expertise


Health Law
read /

M&A
read /

Pharmaceutical
read /